[1]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2020) Cancer Statistics, 2020. CA: A Cancer Journal for Clinicians, 70, 7-30.
https://doi.org/10.3322/caac.21590
|
[2]
|
Zeng, H., Chen, W., Zheng, R., et al. (2018) Changing Cancer Survival in China during 2003-15: A Pooled Analysis of 17 Population-Based Cancer Registries. The Lancet Global Health, 6, e555-e567.
https://doi.org/10.1016/S2214-109X(18)30127-X
|
[3]
|
Rawla, P., Sunkara, T. and Gaduputi, V. (2019) Epidemi-ology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World Journal of Oncology, 10, 10-27. https://doi.org/10.14740/wjon1166
|
[4]
|
Matsubayashi, H., Ishiwatari, H., Sasaki, K., Uesaka, K. and Ono, H. (2020) Detecting Early Pancreatic Cancer: Current Problems and Future Prospects. Gut and Liver, 14, 30-36. https://doi.org/10.5009/gnl18491
|
[5]
|
Xia, C., Dong, X., Li, H., et al. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends, and Determinants. Chinese Medical Journal, 135, 584-590. https://doi.org/10.1097/CM9.0000000000002108
|
[6]
|
Owens, D.K., Davidson, K.W., Krist, A.H., et al. (2019) Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA, 322, 438-444. https://doi.org/10.1001/jama.2019.10232
|
[7]
|
Goggins, M., Overbeek, K.A., Brand, R., et al. (2020) Management of Patients with Increased Risk for Familial Pancreatic Cancer: Updated Recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut, 69, 7-17. https://doi.org/10.1136/gutjnl-2019-319352
|
[8]
|
Guo, Q., Kang, M., Zhang, B., et al. (2010) Elevated Levels of CA 19-9 and CEA in Pancreatic Cancer-Associated Diabetes. Journal of Cancer Research and Clinical Oncology, 136, 1627-1631.
https://doi.org/10.1007/s00432-010-0820-0
|
[9]
|
Noy, A. and Bilezikian, J.P. (1994) Clinical Review 63: Diabetes and Pancreatic Cancer: Clues to the Early Diagnosis of Pancreatic Malignancy. The Journal of Clinical Endocrinology and Metabolism, 79, 1223-1231.
https://doi.org/10.1210/jcem.79.5.7962312
|
[10]
|
Cuzick, J. and Babiker, A.G. (1989) Pancreatic Cancer, Alcohol, Diabetes Mellitus and Gall-Bladder Disease. International Journal of Cancer, 43, 415-421. https://doi.org/10.1002/ijc.2910430312
|
[11]
|
Cersosimo, E., Pisters, P.W.T., Pesola, G., et al. (1991) Insulin Se-cretion and Action in Patients with Pancreatic Cancer. Cancer, 67, 486-493. https://doi.org/10.1002/1097-0142(19910115)67:2<486::AID-CNCR2820670228>3.0.CO;2-1
|
[12]
|
Permert, J., Ihse, I., Jorfeldt, L., et al. (1993) Pancreatic Cancer Is Associated with Impaired Glucose Metabolism. The European Journal of Surgery = Acta Chirurgica, 159, 101-107.
|
[13]
|
Pannala, R., Leirness, J.B., Bamlet, W.R., et al. (2008) Prevalence and Clinical Profile of Pancreatic Cancer-Asso- ciated Diabetes Mellitus. Gastroenterology, 134, 981-987. https://doi.org/10.1053/j.gastro.2008.01.039
|
[14]
|
Chari, S.T., Leibson, C.L., Rabe, K.G., et al. (2008) Pancreatic Cancer-Associated Diabetes Mellitus: Prevalence and Temporal Association with Diagnosis of Cancer. Gastroenterology, 134, 95-101.
https://doi.org/10.1053/j.gastro.2007.10.040
|
[15]
|
Pannala, R., Basu, A., Petersen, G.M. and Chari, S.T. (2009) New-Onset Diabetes: A Potential Clue to the Early Diagnosis of Pancreatic Cancer. The Lancet Oncology, 10, 88-95. https://doi.org/10.1016/S1470-2045(08)70337-1
|
[16]
|
Illés, D., Terzin, V., Holzinger, G., et al. (2016) New-Onset Type 2 Diabetes Mellitus—A High-Risk Group Suitable for the Screening of Pancreatic Cancer? Pancreatology, 16, 266-271. https://doi.org/10.1016/j.pan.2015.12.005
|
[17]
|
Ben, Q., Xu, M., Ning, X., et al. (2011) Diabetes Mellitus and Risk of Pancreatic Cancer: A Meta-Analysis of Cohort Studies. European Journal of Cancer, 47, 1928-1937. https://doi.org/10.1016/j.ejca.2011.03.003
|
[18]
|
Ballotari, P., Vicentini, M., Manicardi, V., et al. (2017) Diabetes and Risk of Cancer Incidence: Results from a Population-Based Cohort Study in Northern Italy. BMC Cancer, 17, Article No. 703.
https://doi.org/10.1186/s12885-017-3696-4
|
[19]
|
Berger, S.M., Gislason, G., Moore, L.L., et al. (2016) Associa-tions between Metabolic Disorders and Risk of Cancer in Danish Men and Women—A Nationwide Cohort Study. BMC Cancer, 16, Article No. 133.
https://doi.org/10.1186/s12885-016-2122-7
|
[20]
|
Dankner, R., Boffetta, P., Balicer, R.D., et al. (2016) Time-Dependent Risk of Cancer after a Diabetes Diagnosis in a Cohort of 2.3 Million Adults. American Journal of Epidemiology, 183, 1098-106. https://doi.org/10.1093/aje/kwv290
|
[21]
|
Kang, Y.M., Kim, Y.-J., Park, J.-Y., Lee, W.J. and Jung, C.H. (2016) Mortality and Causes of Death in a National Sample of Type 2 Diabetic Patients in Korea from 2002 to 2013. Cardiovascular Diabetology, 15, Article No. 131.
https://doi.org/10.1186/s12933-016-0451-0
|
[22]
|
Lin, C.-C., Chiang, J.-H., Li, C.-I., et al. (2014) Cancer Risks among Patients with Type 2 Diabetes: A 10-Year Follow-up Study of a Nationwide Population-Based Cohort in Taiwan. BMC Cancer, 14, Article No. 381.
https://doi.org/10.1186/1471-2407-14-381
|
[23]
|
Mizuno, S., Nakai, Y., Isayama, H., et al. (2013) Diabetes Is a Useful Diagnostic Clue to Improve the Prognosis of Pancreatic Cancer. Pancreatology, 13, 285-289. https://doi.org/10.1016/j.pan.2013.03.013
|
[24]
|
Maitra, A., Sharma, A., Brand, R.E., et al. (2018) A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer. Pancreas, 47, 1244-1248.
https://doi.org/10.1097/MPA.0000000000001169
|
[25]
|
Sah, R., Nagpal, S., Mukhopadhyay, D. and Chari, S.T. (2013) New Insights into Pancreatic Cancer-Induced Paraneoplastic Diabetes. Nature Reviews Gastroenterology & Hepatology, 10, 423-433. https://doi.org/10.1038/nrgastro.2013.49
|
[26]
|
Bo, X., Shi, J., Liu, R., et al. (2019) Using the Risk Factors of Pancreatic Cancer and Their Interactions in Cancer Screening: A Case-Control Study in Shanghai, China. Annals of Global Health, 85, 103. https://doi.org/10.5334/aogh.2463
|
[27]
|
La Torre, G., Sferrazza, A., Gualano, M.R., et al. (2014) Investigating the Synergistic Interaction of Diabetes, Tobacco Smoking, Alcohol Con-sumption, and Hypercholesterolemia on the Risk of Pancreatic Cancer: A Case-Control Study in Italy. BioMed Research International, 2014, Article ID: 481019. https://doi.org/10.1155/2014/481019
|
[28]
|
Petit, J.M., Vaillant, G., Olsson, N.O., et al. (1994) Elevated Serum CA19-9 Levels in Poorly Controlled Diabetic Patients. Relationship with Lewis Blood group. Gastroenterologie Clinique et Biologique, 18, 17-20.
|